Civica Rx (Civica, Inc.) announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications...
Read moreJohnson & Johnson (J&J) unit Janssen Pharmaceutical has partnered with the US Department of Health & Human Services (HHS) to...
Read moreThe transaction is expected to be completed in the third quarter of Catalent’s 2020 financial year, and is subject to...
Read moreApplied BioMath , the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and...
Read moreAvacta Group plc , the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has signed a...
Read moreWPD PharmaceuticalsInc. ,a clinical stage pharmaceutical company, provides this update on the completed acquisition of exclusive sublicenses for two drug...
Read moreGenome & Company is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with...
Read moreBridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug...
Read moreCivica Rx announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica...
Read moreThe Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.